This program will review the optimal antiplatelet treatments for patients requiring anticoagulation. Attendees benefit from a comprehensive review of the latest guidelines and information to give them evidence-based approaches for avoiding bleeding in patients undergoing PCI.

This program will look at the correct timing and modality of transition from intravenous to oral platelet inhibition in patients.